Parsing the relationships among gut microbiome, neurotransmitter metabolome, glymphatic function, and cognition across healthy elderly, mild cognitive impairment, and probable Alzheimer's disease.
The gut microbiome, neurotransmitter metabolome, and a variety of glymphatic markers were measured in patients with clinically diagnosed probable AD and showed a wide range of associations, which may inform future preventive and therapeutic interventions by targeting the established pathways.